Immediate Impact
1 by Nobel laureates 56 standout
Citing Papers
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
2024 Standout
Works of S.-H. Lee being referenced
A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| S.-H. Lee | 29 | 52 | 184 | 185 | 14 | 310 | |
| K Kim | 42 | 41 | 78 | 189 | 15 | 364 | |
| Qing Zhang | 16 | 23 | 90 | 220 | 19 | 333 | |
| Giuseppe Pugliese | 12 | 40 | 57 | 242 | 16 | 328 | |
| Takeo Iwasaki | 17 | 15 | 186 | 110 | 13 | 350 | |
| Horst Wagner | 4 | 53 | 177 | 207 | 10 | 350 | |
| Christine A. Trinkle | 15 | 47 | 51 | 100 | 16 | 273 | |
| Chris Wakeman | 12 | 149 | 75 | 194 | 19 | 360 | |
| Takeshi Fukawa | 17 | 17 | 168 | 84 | 14 | 355 | |
| Vincent Armenio | 13 | 59 | 47 | 241 | 13 | 303 | |
| Jaymin Jhaveri | 3 | 64 | 138 | 101 | 19 | 309 |
All Works
Login with ORCID to disown or claim papers
Loading papers...